
News|Articles|March 30, 2026
This Week on NeurologyLive® — March 30, 2026
Author(s)Isabella Ciccone, MPH
Listen
0:00 / 0:00
Key Takeaways
- Weekly editorial outlook highlights upcoming neurology content and promotes a consistent publishing cadence.
- A curated set of “hot topics” is previewed, with explicit note that additional stories will run beyond the featured items.
Here's some of what is coming soon to NeurologyLive® this week.
Advertisement
Every week, the NeurologyLive® staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting on the website. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!
Click through the slides below to see what you can expect from our team this week. Click any slide to check out the content.
—————————————————
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
2
AD109 Accepted NDA, AXS-12 FDA Submission, Phase 2 CELIA Study Results
3
Anti-Tau Agent Diranersen Slows Cognitive Decline Across Multiple Endpoints in Phase 2 CELIA Trial, Biogen to Advance to Phase 3
4
POLARIS-AD Phase 3 Trial of PDE5 Inhibitor AR1001 Completes Treatment Phase With Favorable Safety Profile
5


















